VRTX
VERTEX PHARMACEUTICALS INC / MAData updated: 2026-04-21 · Current price: $436.95
Composite Score: 70
HOLD
Score: 70 / 100
Valuation is within reasonable range — hold and wait for a better entry point
Profitability
75
Growth
64
Valuation
33
Moat
38
Stability
100
Business Quality
ROE · Gross Margin · Revenue Growth
ROE
21.2%
Quality threshold: > 15%
Gross Margin
86.2%
Quality threshold: > 40%
Rev. Growth (5yr)
12.2%
Quality threshold: > 5%
5-Year ROE: 21.2% → -3.3% → 20.6% → 23.9% → 23.2%|5-Year Gross Margin: 86.2% → 86.1% → 87.2% → 87.9% → 88.1%
Financial Strength
Debt Ratio · Free Cash Flow · Current Ratio
Debt / Equity
0.37
Quality threshold: < 0.5
FCF (5yr avg)
3.0B $
Quality threshold: > 0
Current Ratio
3.68x
Quality threshold: > 1.5
FCF Trend (B USD)
$4.1B2022
$-0.2B2023
$3.7B2024
$4.3B2025
$2.9B2026
Valuation
Intrinsic Value · Margin of Safety
Owner Earnings
$3.7B
Net Income + D&A - CapEx
Current Price
$436.95
Source: Alpha Vantage
💡 Valuation Note: Intrinsic value based on DCF model, adjustable above. Visit the DCF Calculator for full three-stage valuation.
Complete Your Analysis
"Price is what you pay. Value is what you get."
— Warren Buffett